Anticipating PTSD in severe COVID survivors: the case for screen-and-treat: El caso para detección y tratamiento

Talya Greene; Sharif El-Leithy; Jo Billings; Idit Albert; Jennifer Birch; Mari Campbell; Kim Ehntholt; Lorna Fortune; Nicola Gilbert; Nick Grey; Laurinne Hana; Helen Kennerley; Deborah Lee; Sarah Lunn; Dominic Murphy; Mary Robertson; Dorothy Wade; Chris R. Brewin; Michael A.P. Bloomfield

doi:10.1080/20008198.2021.1959707

Anticipating PTSD in severe COVID survivors: the case for screen-and-treat: El caso para detección y tratamiento

Talya Greene
, Sharif El-Leithy
, Jo Billings
, Idit Albert
, Jennifer Birch
, Mari Campbell
, Kim Ehntholt
, Lorna Fortune
, Nicola Gilbert
, Nick Grey
, Laurinne Hana
, Helen Kennerley
, Deborah Lee
, Sarah Lunn
, Dominic Murphy
, Mary Robertson
, Dorothy Wade
, Chris R. Brewin
, Michael A.P. Bloomfield^*

^*Corresponding author for this work

University of Haifa
UCL University College London
South West London and St George's Mental Health NHS Trust
SLaM South London and Maudsley NHS Foundation Trust
King's College London
University of East Anglia
Norfolk and Norwich University Hospitals NHS Foundation Trust
Royal Free London NHS FT and UCL
St Pancras Hospital
Barnet Enfield & Haringey MHT
North Middlesex University Hospital NHS Trust
Sussex Partnership NHS Foundation Trust
School of Psychology
University of Sussex
UCL Hospitals NHS Foundation Trust
Oxford Cognitive Therapy Centre
University of Oxford
Berkshire Healthcare NHS Foundation Trust
Whittington Health NHS Trust

Research output: Contribution to journal › Letter › peer-review

11 Citations (Scopus)

Abstract

Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

Original language	English
Article number	1959707
Journal	European journal of psychotraumatology
Volume	13
Issue number	1
Early online date	26 Jan 2022
DOIs	https://doi.org/10.1080/20008198.2021.1959707
Publication status	Published - 2022

Keywords

critical care
intensive care
long COVID
mental health screening
Psychological trauma
PTSD assessment

Access to Document

10.1080/20008198.2021.1959707

Cite this

Greene, T., El-Leithy, S., Billings, J., Albert, I., Birch, J., Campbell, M., Ehntholt, K., Fortune, L., Gilbert, N., Grey, N., Hana, L., Kennerley, H., Lee, D., Lunn, S., Murphy, D., Robertson, M., Wade, D., Brewin, C. R., & Bloomfield, M. A. P. (2022). Anticipating PTSD in severe COVID survivors: the case for screen-and-treat: El caso para detección y tratamiento. European journal of psychotraumatology, 13(1), Article 1959707. https://doi.org/10.1080/20008198.2021.1959707

@article{ee68951c5d1a4816a315a8eda8de0124,

title = "Anticipating PTSD in severe COVID survivors: the case for screen-and-treat: El caso para detecci{\'o}n y tratamiento",

abstract = "Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30\% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.",

keywords = "critical care, intensive care, long COVID, mental health screening, Psychological trauma, PTSD assessment",

author = "Talya Greene and Sharif El-Leithy and Jo Billings and Idit Albert and Jennifer Birch and Mari Campbell and Kim Ehntholt and Lorna Fortune and Nicola Gilbert and Nick Grey and Laurinne Hana and Helen Kennerley and Deborah Lee and Sarah Lunn and Dominic Murphy and Mary Robertson and Dorothy Wade and Brewin, \{Chris R.\} and Bloomfield, \{Michael A.P.\}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Informa UK Limited, trading as Taylor \& Francis Group.",

year = "2022",

doi = "10.1080/20008198.2021.1959707",

language = "English",

volume = "13",

journal = "European journal of psychotraumatology",

issn = "2000-8198",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

Greene, T, El-Leithy, S, Billings, J, Albert, I, Birch, J, Campbell, M, Ehntholt, K, Fortune, L, Gilbert, N, Grey, N, Hana, L, Kennerley, H, Lee, D, Lunn, S, Murphy, D, Robertson, M, Wade, D, Brewin, CR & Bloomfield, MAP 2022, 'Anticipating PTSD in severe COVID survivors: the case for screen-and-treat: El caso para detección y tratamiento', European journal of psychotraumatology, vol. 13, no. 1, 1959707. https://doi.org/10.1080/20008198.2021.1959707

TY - JOUR

T1 - Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

T2 - El caso para detección y tratamiento

AU - Greene, Talya

AU - El-Leithy, Sharif

AU - Billings, Jo

AU - Albert, Idit

AU - Birch, Jennifer

AU - Campbell, Mari

AU - Ehntholt, Kim

AU - Fortune, Lorna

AU - Gilbert, Nicola

AU - Grey, Nick

AU - Hana, Laurinne

AU - Kennerley, Helen

AU - Lee, Deborah

AU - Lunn, Sarah

AU - Murphy, Dominic

AU - Robertson, Mary

AU - Wade, Dorothy

AU - Brewin, Chris R.

AU - Bloomfield, Michael A.P.

PY - 2022

Y1 - 2022

N2 - Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

AB - Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

KW - critical care

KW - intensive care

KW - long COVID

KW - mental health screening

KW - Psychological trauma

KW - PTSD assessment

UR - https://www.scopus.com/pages/publications/85123725184

U2 - 10.1080/20008198.2021.1959707

DO - 10.1080/20008198.2021.1959707

M3 - Letter

AN - SCOPUS:85123725184

SN - 2000-8198

VL - 13

JO - European journal of psychotraumatology

JF - European journal of psychotraumatology

IS - 1

M1 - 1959707

ER -

Anticipating PTSD in severe COVID survivors: the case for screen-and-treat: El caso para detección y tratamiento

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this